Attività
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Simon Read
CTO | Chief Tech/Sci/R&D Officer | 53 | 04/04/16 |
Chief Tech/Sci/R&D Officer | 47 | 01/07/16 | |
Alonso Ricardo
CTO | Chief Tech/Sci/R&D Officer | 46 | 01/01/10 |
Investor Relations Contact | - | - | |
Corporate Officer/Principal | - | - | |
Peter DiRoma
LAW | General Counsel | - | 01/11/18 |
Kerry Black
PRN | Corporate Officer/Principal | - | 01/03/10 |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
Charl van Zyl
BRD | Director/Board Member | 57 | 02/04/20 |
Director/Board Member | 63 | 02/04/20 | |
Abhinav Kumar
BRD | Director/Board Member | - | 02/04/20 |
Denelle Waynick
BRD | Director/Board Member | 57 | 02/04/20 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 47 328 875 | 45 417 827 ( 95,96 %) | 0 | 95,96 % |
Coordinate società
![Indirizzo Ra Pharmaceuticals, Inc.](https://cdn.zonebourse.com/static/address/31728980.png)
Settore
Variaz. 1 gen. | Capi. | |
---|---|---|
+20,17% | 127 Mrd | |
+24,67% | 117 Mrd | |
+25,44% | 27,67 Mrd | |
-17,74% | 20,33 Mrd | |
-15,17% | 16,79 Mrd | |
-15,21% | 15,63 Mrd | |
+11,91% | 14,84 Mrd | |
-47,10% | 14,65 Mrd | |
+54,50% | 14,43 Mrd |